Get the Stockscreener App
93.73
0.17%
0.09
Merit Medical Systems Inc stock is traded at $93.73, with a volume of 37,244.
It is up +0.17% in the last 24 hours and down -1.94% over the past month.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
See More
Previous Close:
$93.64
Open:
$93.38
24h Volume:
37,244
Relative Volume:
0.05
Market Cap:
$5.54B
Revenue:
$1.33B
Net Income/Loss:
$120.04M
P/E Ratio:
45.72
EPS:
2.05
Net Cash Flow:
$172.71M
1W Performance:
-2.80%
1M Performance:
-1.94%
6M Performance:
-10.51%
1Y Performance:
+14.14%
1-Day Range:
$93.00
$93.86
1-Week Range:
$91.73
$96.53
52-Week Range:
$80.02
$111.45
Merit Medical Systems Inc Stock (MMSI) Company Profile
Name
Merit Medical Systems Inc
Sector
Industry
Phone
(801) 253-1600
Address
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Compare MMSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
93.72 | 5.70B | 1.33B | 120.04M | 172.71M | 2.05 |
|
ISRG
Intuitive Surgical Inc
|
551.98 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
170.23 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
84.91 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
245.60 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.74 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Initiated | JP Morgan | Overweight |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-28-24 | Initiated | Robert W. Baird | Outperform |
| Apr-11-24 | Initiated | CL King | Buy |
| Feb-07-24 | Initiated | BofA Securities | Neutral |
| Dec-21-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Dec-20-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-05-21 | Upgrade | Needham | Hold → Buy |
| Sep-28-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Feb-25-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-12-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Sep-24-19 | Initiated | Oppenheimer | Outperform |
| Sep-10-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Needham | Buy → Hold |
| Jul-26-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-02-18 | Reiterated | Needham | Buy |
| Aug-07-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Jul-24-18 | Reiterated | Needham | Buy |
| Jun-01-18 | Reiterated | Needham | Buy |
| May-18-18 | Reiterated | SunTrust | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Apr-20-18 | Initiated | Needham | Buy |
| Mar-01-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Aug-28-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-20-17 | Initiated | BofA/Merrill | Buy |
| Jun-20-17 | Initiated | SunTrust | Buy |
| Apr-05-17 | Initiated | Wells Fargo | Outperform |
View All
Merit Medical Systems Inc Stock (MMSI) Latest News
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention? - Yahoo Finance
Have Merit Medical Systems Insiders Been Selling Stock? - simplywall.st
Merit Medical (MMSI) CEO Sells Significant Shareholding | MMSI S - GuruFocus
Merit Medical CEO sells $1.93M shares of shares - TipRanks
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock - Investing.com
Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today - Benzinga
Prostatic Artery Embolization Market Set to Witness Rising AdoptionMerit Medical, Boston Scientific - openPR.com
When the Price of (MMSI) Talks, People Listen - news.stocktradersdaily.com
Merit Medical Systems (MMSI) Target Price Raised to $110 by Pipe - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent De - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent Developments | MMSI Stock News - GuruFocus
Merit Medical Systems acquires Biolife Delaware in $120 million deal - MSN
Merit Medical Systems: A Quality Business Judged On Its Merits (NASDAQ:MMSI) - Seeking Alpha
Canaccord raises Merit Medical price target to $112 By Investing.com - Investing.com South Africa
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio - sharewise
Canaccord raises Merit Medical price target to $112 - Investing.com Australia
MMSI: Target Price Raised by Canaccord Genuity with Buy Rating M - GuruFocus
Manatee medical manufacturer acquired for $120 million - Business Observer
Merit buys hemostatic device maker Biolife for $120M - MedTech Dive
Merit Medical Systems (MMSI) Target Price Increased by Wells Fargo | MMSI Stock News - GuruFocus
Merit Medical acquires Biolife Delaware - Medical Buyer
Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI) - simplywall.st
Merit Medical (MMSI) Price Target Raised by Canaccord Analyst | - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Following Acquis - GuruFocus
Interventional Neuroradiology Market Growth, Trends & - openPR.com
Merit Medical acquires fellow interventional radiology vendor Biolife for $120M - Radiology Business
Merit Medical acquires Biolife for enhanced hemostasis By Investing.com - Investing.com South Africa
Merit Medical Acquires Biolife Delaware for $120 Million - TipRanks
Merit Medical acquires Biolife for enhanced hemostasis - Investing.com Australia
Merit Medical Systems, Inc. acquired Biolife, LLC for $120 million. - marketscreener.com
MMSI: Analyst Reiterates Buy Rating with $108 Target | MMSI Stoc - GuruFocus
Merit Medical Buys Biolife Delaware for $120 Million - Medical Product Outsourcing
Merit Medical Systems, Inc. Updates Earning Guidance for the Fiscal Year Ending December 31,2025 - marketscreener.com
Merit Medical Systems (MMSI) Adjusts FY25 Revenue Expectations | - GuruFocus
Merit Medical (MMSI) Completes Acquisition of Biolife Delaware | - GuruFocus
Merit Medical (MMSI) Acquires Biolife Delaware in $120 Million D - GuruFocus
Merit Medical Systems Acquires Biolife Delaware For About $120 Mln; Confirms Annual Outlook - Nasdaq
Merit Medical Systems Buys Biolife Delaware - marketscreener.com
Merit Medical Acquires Biolife Delaware, L.L.C. | MMSI Stock News - GuruFocus
Merit Medical Acquires Biolife Delaware, L.L.C. - The Manila Times
Merit Medical Systems, Inc. Acquires Biolife Delaware, L.L.C. to Enhance Hemostasis Solutions Portfolio and Revenue Growth - Nasdaq
Merit Medical's $120M Biolife Acquisition Expands Global Hemostasis Portfolio with StatSeal Technology - Stock Titan
Merit Medical Systems Shareholders Approve Key Proposals - TipRanks
Zacks Research Issues Pessimistic Estimate for MMSI Earnings - Defense World
Reflecting On Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks’ Q1 Earnings: Merit Medical Systems (NASDAQ:MMSI) - Yahoo Finance
Merit Medical Inks Deal for Ostial Solutions - Medical Product Outsourcing
Coating Process Spurs Warning Letter for Merit Medical - Medical Product Outsourcing
Merit Medical Expands Virginia Facility - Medical Product Outsourcing
Merit Medical Posts Better-Than-Expected Q3 Earnings - Medical Product Outsourcing
Merit Medical Posts Better-That-Expected Third-Quarter Earnings - Medical Product Outsourcing
Merit Medical Systems Inc Stock (MMSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):